Javier Gavira - Publications

International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal.

Journal: International journal of cancer

Published: August 29, 2025

Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 29, 2025

The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.

Journal: Cancers

Published: July 12, 2024

What About Variant Histologies in Bladder Cancer?

Journal: European urology focus

Published: February 21, 2024

Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 14, 2024

Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 13, 2023

Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021.

Journal: Clinical genitourinary cancer

Published: April 15, 2023

Immunotherapy-induced isolated ACTH deficiency in cancer therapy.

Journal: Endocrine-related cancer

Published: September 24, 2021

Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective study.

Journal: International journal of cancer

Published: August 10, 2021

Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.

Journal: Cancer immunology, immunotherapy : CII

Published: July 21, 2020